• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].

作者信息

Ohsawa S, Kondo Y, Shiroto H, Masuko H, Fukushima T, Kataoka A, Ohmori K, Sawaguchi Y, Baba E, Takahashi T

机构信息

First Department of Surgery, Hokkaido University School of Medicine, Sapporo, Japan.

出版信息

Gan To Kagaku Ryoho. 1992 Nov;19(13):2189-93.

PMID:1444485
Abstract

We have measured urinary tegafur (FT), 5-FU and uracil concentrations after UFT oral administration (300 mg daily for 7 days) to confirm drug-taking compliance in the 17 cases undergone gastrectomy. Urinary FT and 5-FU concentrations reached to the plateau 2 and 3 days after administration, respectively, and were maintained until the day after termination of administration. Subsequently, FT and 5-FU concentrations also decreased about 50% at 2 day, 20% at 3 day, 10% of the plateau values at 4 day after termination, respectively. The mean plateau value of urinary FT was 12.9 +/- 6.8 micrograms/dl, and that of urinary 5-FU was 0.67 +/- 0.50 microgram/dl. On the other hand, uracil concentration, was not different before and after administration because of the uracil being present endogenously. Therefore, it was suggested that measurement of urinary FT and 5-FU concentrations is useful for confirmation of UFT-taking compliance.

摘要

相似文献

1
[A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2189-93.
2
[Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2181-7.
3
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.接受持续5-氟尿嘧啶输注的患者与口服尿嘧啶加N1-(2'-四氢呋喃基)-5-氟尿嘧啶患者的5-氟尿嘧啶药代动力学比较。
Clin Cancer Res. 1998 Sep;4(9):2085-8.
4
[Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Gan To Kagaku Ryoho. 1992 Nov;19(13):2175-80.
5
[The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Gan To Kagaku Ryoho. 1988 Aug;15(8):2319-23.
6
[Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
Gan To Kagaku Ryoho. 1989 Dec;16(12):3755-62.
7
[Studies on 5-FU concentration in serum and prostate cancer tissue after oral administration of UFT].口服优福定后血清及前列腺癌组织中5-氟尿嘧啶浓度的研究
Hinyokika Kiyo. 1991 Jul;37(7):711-5.
8
[Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].接受维持性透析的癌症患者中优福定的药代动力学研究
Gan To Kagaku Ryoho. 1995 Feb;22(2):239-44.
9
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.优福定(UFT)与亚叶酸:其在口腔癌治疗中的临床进展及治疗潜力综述
Anticancer Drugs. 1998 Jul;9(6):479-90.
10
[The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].[胃切除术对口服优福定患者血清5-氟尿嘧啶浓度的影响]
Gan No Rinsho. 1987 Apr;33(4):377-81.

引用本文的文献

1
Effect of gastrectomy on the pharmacokinetics of tegafur, uracil, and 5-fluorouracil after oral administration of a 1:4 tegafur and uracil combination.胃切除术后口服替加氟与尿嘧啶 1:4 组合后对替加氟、尿嘧啶和 5-氟尿嘧啶药代动力学的影响。
Cancer Chemother Pharmacol. 1994;33(6):445-9. doi: 10.1007/BF00686498.